<DOC>
	<DOC>NCT00867295</DOC>
	<brief_summary>This randomized trial is determining the role of antibiotic prophylaxis in the prevention of the infectious complications in patients carrying out totally implantable venous access device.</brief_summary>
	<brief_title>Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<criteria>Older than 18 years of age Have solid tumor White cells &gt;4000 Platelets &gt;100.000 Prothrombin time in normal range Drug allergy Diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>implantable catheters</keyword>
	<keyword>Indwelling Catheters</keyword>
	<keyword>infection</keyword>
	<keyword>cefazolin sodium</keyword>
	<keyword>prophylactic</keyword>
	<keyword>antibiotic</keyword>
	<keyword>totally implantable venous access device</keyword>
	<keyword>cancer patients</keyword>
</DOC>